Welcome to LookChem.com Sign In|Join Free

CAS

  • or

211494-29-0

4-(6-AMINO-2-PYRIDINYL)-3-METHOXYPHENOL is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

211494-29-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 211494-29-0 Structure

  • Basic information

    1. Product Name: 4-(6-AMINO-2-PYRIDINYL)-3-METHOXYPHENOL
    2. Synonyms: 4-(6-AMINO-2-PYRIDINYL)-3-METHOXYPHENOL
    3. CAS NO:211494-29-0
    4. Molecular Formula: C12H12N2O2
    5. Molecular Weight: 216.24
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 211494-29-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 400.3°C at 760 mmHg
    3. Flash Point: 195.9°C
    4. Appearance: /
    5. Density: 1.252g/cm3
    6. Vapor Pressure: 5.56E-07mmHg at 25°C
    7. Refractive Index: 1.633
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 4-(6-AMINO-2-PYRIDINYL)-3-METHOXYPHENOL(CAS DataBase Reference)
    11. NIST Chemistry Reference: 4-(6-AMINO-2-PYRIDINYL)-3-METHOXYPHENOL(211494-29-0)
    12. EPA Substance Registry System: 4-(6-AMINO-2-PYRIDINYL)-3-METHOXYPHENOL(211494-29-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 211494-29-0(Hazardous Substances Data)

211494-29-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 211494-29-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,1,4,9 and 4 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 211494-29:
(8*2)+(7*1)+(6*1)+(5*4)+(4*9)+(3*4)+(2*2)+(1*9)=110
110 % 10 = 0
So 211494-29-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2O2/c1-16-11-7-8(15)5-6-9(11)10-3-2-4-12(13)14-10/h2-7,15H,1H3,(H2,13,14)

211494-29-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(6-amino-1H-pyridin-2-ylidene)-3-methoxycyclohexa-2,5-dien-1-one

1.2 Other means of identification

Product number -
Other names Phenol,4-(6-amino-2-pyridinyl)-3-methoxy

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:211494-29-0 SDS

211494-29-0Upstream product

211494-29-0Relevant articles and documents

New pharmaceutical combinations for NOS inhibitors

-

, (2008/06/13)

The present invention relates to new pharmaceutical uses for compounds that exhibit activity as nitric oxide synthase (NOS) inhibitors. Specifically, it relates to the use of NOS inhibitors, particularly selective neuronal NOS (nNOS) inhibitors, alone or in combination with another active agent, in particular, either an SSRI or an NK-1 receptor antagonist, for the treatment of disorders or conditions the treatment which can be effected or facilitated by altering circadian rhythms. Examples of such disorders and conditions are blindness, obesity, seasonal affective disorder, bipolar disorder; jet lag, circadian sleep rhythms disorder, sleep deprivation, parasomnias, REM sleep disorders, hypersomnia, sleep-wake cycle disorders, narcolepsy and sleep disorders associated with shift work or irregular work schedules; nocturnal enuresis, and restless-legs syndrome.

2-AMINO-6-(2-SUBSTITUTED-4-PHENOXY)-SUBSTITUTED-PYRIDINES

-

, (2008/06/13)

This present invention relates to compounds of the formula wherein G, R1 and R2 are defined as in the specification, to pharmaceutical compositions containing them and to their use in the treatment and prevention of central nervous system and other disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 211494-29-0